Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS Trial.
Saved in:
| Title: | Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS Trial. |
|---|---|
| Authors: | Einarsson GG; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom., Lee AJ; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom., Alfahl Z; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom., Kerrigan L; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom., Eustace JA; Cork Centre for Cystic Fibrosis (3CF), Cork University Hospital, University College Cork, Wilton, Cork, Ireland.; The HRB funded Clinical Research Facility, University College Cork, Cork, Ireland., Weldon S; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom., Plant BJ; Cork Centre for Cystic Fibrosis (3CF), Cork University Hospital, University College Cork, Wilton, Cork, Ireland.; The HRB funded Clinical Research Facility, University College Cork, Cork, Ireland.; Department of Medicine, University College Cork, Cork, Ireland., Elborn JS; School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom., Taggart CC; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom., Mall MA; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Center for Lung Research (DZL), associated partner site Berlin, Berlin, Germany.; German Center for Child and Adolescent Health (DZKJ), partner site Berlin, Berlin, Germany.; Cluster of Excellence ImmunoPreCept, Charité - Universitätsmedizin Berlin, Berlin, Germany., Tunney MM; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom. |
| Source: | American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Thoracic Society Country of Publication: England NLM ID: 9421642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42371757 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Einarsson+GG%22">Einarsson GG</searchLink>; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lee+AJ%22">Lee AJ</searchLink>; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Alfahl+Z%22">Alfahl Z</searchLink>; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kerrigan+L%22">Kerrigan L</searchLink>; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Eustace+JA%22">Eustace JA</searchLink>; Cork Centre for Cystic Fibrosis (3CF), Cork University Hospital, University College Cork, Wilton, Cork, Ireland.; The HRB funded Clinical Research Facility, University College Cork, Cork, Ireland.<br /><searchLink fieldCode="AU" term="%22Weldon+S%22">Weldon S</searchLink>; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Plant+BJ%22">Plant BJ</searchLink>; Cork Centre for Cystic Fibrosis (3CF), Cork University Hospital, University College Cork, Wilton, Cork, Ireland.; The HRB funded Clinical Research Facility, University College Cork, Cork, Ireland.; Department of Medicine, University College Cork, Cork, Ireland.<br /><searchLink fieldCode="AU" term="%22Elborn+JS%22">Elborn JS</searchLink>; School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Taggart+CC%22">Taggart CC</searchLink>; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mall+MA%22">Mall MA</searchLink>; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Center for Lung Research (DZL), associated partner site Berlin, Berlin, Germany.; German Center for Child and Adolescent Health (DZKJ), partner site Berlin, Berlin, Germany.; Cluster of Excellence ImmunoPreCept, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Tunney+MM%22">Tunney MM</searchLink>; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229421642%22">American journal of respiratory and critical care medicine</searchLink> [Am J Respir Crit Care Med] 2026 Jun 29. <i>Date of Electronic Publication: </i>2026 Jun 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Thoracic+Society%22">American Thoracic Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9421642 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-4970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221073449X%22">1073449X </searchLink><i>NLM ISO Abbreviation: </i>Am J Respir Crit Care Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42371757 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/ajrccm/aamag336 Languages: – Code: eng Text: English Titles: – TitleFull: Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Einarsson GG – PersonEntity: Name: NameFull: Lee AJ – PersonEntity: Name: NameFull: Alfahl Z – PersonEntity: Name: NameFull: Kerrigan L – PersonEntity: Name: NameFull: Eustace JA – PersonEntity: Name: NameFull: Weldon S – PersonEntity: Name: NameFull: Plant BJ – PersonEntity: Name: NameFull: Elborn JS – PersonEntity: Name: NameFull: Taggart CC – PersonEntity: Name: NameFull: Mall MA – PersonEntity: Name: NameFull: Tunney MM IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 06 Text: 2026 Jun 29 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1535-4970 Titles: – TitleFull: American journal of respiratory and critical care medicine Type: main |
| ResultId | 1 |
